Delving into the Latest Updates on Hefei Heyuan Pharmaceutical Technology Co. Ltd. with Synapse

Overview

Tags

Immune System Diseases

Hemic and Lymphatic Diseases

Neoplasms

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Hemic and Lymphatic Diseases	1
Immune System Diseases	1
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

PI3Kδ(Phosphatidylinositol 3 kinase delta)	1
AR x IL-6 x TNF-α	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

1

Phase 1 Clinical

Other

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Wogonin ( AR x IL-6 x TNF-α )	Neoplasms More	Phase 1
PI3KD-IN-015 ( PI3Kδ )	B-Cell Malignant Neoplasm More	Preclinical
CHMFL-FLT3-165 ( FLT3 )	Acute Myeloid Leukemia More	Pending